In 2 randomized clinical trials, investigators sought to determine if use of vitamin D supplements improved PFS and RFS for patients with digestive tract cancers.
Pooled analysis finds levels 60 ng/mL are most protective among women aged 55 years and older
A post-hoc analysis of the VIDA study sought to determine if vitamin D levels influence risk for cancer and/or cancer prevention.
Just over half of patients in a standard therapy group had normal bone mineral density after a mean follow-up of 6 years; this contrasted with 93% of patients in a vitamin D supplementation group.
Use of multivitamins prior to a breast cancer diagnosis is associated with reduced symptoms of peripheral neuropathy.
Vitamin B intake appears to be related to lung cancer risk, but only for men or male smokers.
Supplementation with vitamin D3 in premenopausal women does not have a significant effect on breast density percentage, nor does it reduce breast cancer risk.
Regular infusions of high doses of vitamin C safely increased cancer cell sensitivity to treatment in patients with brain and lung cancers.
A series of experiments revealed the mechanism of action by which vitamin C causes cancer cells to die in a cell culture.
Research using cancer cell lines demonstrated that supplementing standard epigenetic therapy with vitamin C enhanced the drug’s antineoplastic action.
